Stuttgart - Delayed Quote EUR

CytomX Therapeutics Inc (6C1.SG)

Compare
0.8410
-0.0885
(-9.52%)
At close: January 10 at 9:35:50 PM GMT+1
All numbers in thousands
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
201,792.0000
260,891.0000
339,411.0000
358,663.0000
Total Liabilities Net Minority Interest
249,239.0000
346,642.0000
339,870.0000
366,437.0000
Total Equity Gross Minority Interest
-47,447.0000
-85,751.0000
-459.0000
-7,774.0000
Total Capitalization
-47,447.0000
-85,751.0000
-459.0000
-7,774.0000
Common Stock Equity
-47,447.0000
-85,751.0000
-459.0000
-7,774.0000
Capital Lease Obligations
13,974.0000
18,057.0000
21,674.0000
24,870.0000
Net Tangible Assets
-49,125.0000
-87,575.0000
-2,429.0000
-9,890.0000
Working Capital
27,023.0000
84,494.0000
232,431.0000
255,902.0000
Invested Capital
-47,447.0000
-85,751.0000
-459.0000
-7,774.0000
Tangible Book Value
-49,125.0000
-87,575.0000
-2,429.0000
-9,890.0000
Total Debt
13,974.0000
18,057.0000
21,674.0000
24,870.0000
Share Issued
67,310.8380
66,228.0460
65,392.7580
48,251.8190
Ordinary Shares Number
67,310.8380
66,228.0460
65,392.7580
48,251.8190
12/31/2020 - 8/28/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers